Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Nardi, Giuseppe ^a   Agostini, Vanessa ^b   Rondinelli, Beatrice ^a   Russo, Emanuele ^b   Bastianini, Barbara ^a   Bini, Giovanni ^b   Bulgarelli, Simona ^b   Cingolani, Emiliano ^a   Donato, Alessia ^c   Gambale, Giorgio ^b   Ranaldi, Giulia ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b BUFALINI HOSPITAL   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CONTROLLED STUDY; COST CONTROL; FEMALE; HEALTH CARE COST; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; THROMBOCYTE COUNT; BLOOD CLOTTING; BLOOD COAGULATION DISORDERS; BLOOD COMPONENT THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; ECONOMICS; HEMORRHAGE; HOSPITAL MORTALITY; INJURY SCALE; ITALY; PLASMA; PROCEDURES; PROSPECTIVE STUDY; RESUSCITATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; FEMALE; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; INJURY SEVERITY SCORE; ITALY; MALE; MIDDLE AGED; PLASMA; PROSPECTIVE STUDIES; RESUSCITATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84925940883     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0817-9     Document Type: Article

References (35)

1. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54:1127-30.
2. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, et al. The STOP the bleeding campaign. Crit Care. 2013;17:136.
3. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care. 2013;17:R76.
4. Nardi G, Agostini V, Rondinelli MB, Bocci G, Di Bartolomeo S, Bini G, et al. Prevention and treatment of trauma induced coagulopathy (TIC): an intended protocol from the Italian Trauma update research group. J Anesthesiol Clin Sci 2013;2:22. doi:10.7243/2049-9752-2-22. www.hoajonline.com/jacs/2049-9752/2/22. Accessed 14 Mar 2015.
5. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care. 2010;14:R52.
6. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62:307-10.
7. CRASH-2 trial collaborators: Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23-32.
8. Giunta Regionale della Regione Emilia Romagna. Ridefinizione delle tariffe relative alla cessione di sangue ed emoderivati fra le Strutture Sanitarie Pubbliche e Private. GPG/2010/1816. 8 Nov 2010.
9. Ruscitti G Tutti i costi delle trasfusioni (all transfusion-related costs) Il Sole 24 Ore Sanità, 7 Jul 2008.
10. Brockamp T, Nienaber U, Mutschler M, Wafaisade A, Peiniger S, Lefering R, et al. Predicting on-going hemorrhage and transfusion requirement after severe trauma: a validation of six scoring systems and algorithms on the TraumaRegister DGU. Crit Care. 2012;16:R129. doi:10.1186/cc11432.
11. Maegele M, Brockamp T, Nienaber U, Probst C, Schoechl H, Görlinger K, et al. Predictive models and algorithms for the need of transfusion including massive transfusion in severely injured patients. Transfus Med Hemother. 2012;39:85-97.
12. Inaba K, Karamanos E, Lustenberger T, Schöchl H, Shulman I, Nelson J, et al. Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. J Am Coll Surg. 2013;216:290-7.
13. Schlimp CJ, Voelckel W, Inaba K, Maegele M, Ponschab M, Schöchl H. Estimation of plasma fibrinogen levels based on hemoglobin, base excess and ISS upon emergency room admission. Crit Care. 2013;17:R137.
14. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy and association with patient outcomes. J Thromb Haemost. 2012;10:1342-51.
15. Khan S, Brohi K, Chana M, Raza I, Stanworth S, Gaarder C, et al. Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg. 2014;76:561-8.
16. Holcomb JB, Fox EE, Zhang X, White N, Wade CE, Cotton BA, et al. Cryoprecipitate use in the PROMMTT study. J Trauma Acute Care Surg. 2013;75:S31-9.
17. Fries D, Innerhofer P, Perger P, Gütl M, Heil S, Hofmann N, et al. Coagulation management in trauma-related massive bleeding: recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI). Anasthesiol Intensivmed Notfallmed Schmerzther. 2010;45:552-61. doi:10.1055/s-0030-1265746. German.
18. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14:R55.
19. Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol. 2004;125:69-73.
20. Hess JR. Resuscitation of trauma-induced coagulopathy. Hematology Am Soc Hematol Educ Program. 2013;2013:664-7. doi:10.1182/asheducation-2013.1.664.
21. Stinger HK, Spinella PC, Perkins JG, Grathwohl KW, Salinas J, Martini WZ, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma. 2008;64:S79-85.
22. Borgman MA, Spinella PC, Holcomb JB, Blackbourne LH, Wade CE, Lefering R, et al. The effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction score. Vox Sang. 2011;101:44-54.
23. Ho AM, Dion PW, Yeung JH, Holcomb JB, Critchley LA, Ng CS, et al. Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology. 2012;116:716-28.
24. Snyder CW, Weinberg JA, McGwin Jr. G, Melton SM, George RL, Reiff DA, et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma. 2009;66:358-64.
25. Cohen MJ, Kutcher M, Redick B, Nelson M, Call M, Knudson MM, et al. Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care Surg. 2013;75:S40-7.
26. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B, the Working Group on Polytrauma of the German Society of Trauma Surgery (DGU). Red blood cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiply injury: a retrospective analysis from the Trauma Registry of the Deuthche Gesellschaft für Unfallschirurie. Vox Sang. 2008;95:112-9.
27. Johansson PI, Stensballe J. Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets-a review of the current literature. Transfusion. 2010;50:701-10.
28. Cotton BA, Gunter OL, Isbell J, Au BK, Robertson AM, Morris Jr. JA, et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma. 2008;64:1177-83.
29. Gunter Jr. OL, Au BK, Isbell JM, Mowery NT, Young PP, Cotton BA. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma. 2008;65:527-34.
30. Magnotti LJ, Zarzaur BL, Fischer PE, Williams RF, Myers AL, Bradburn EH, et al. Improved survival after hemostatic resuscitation: does the emperor have no clothes? J Trauma. 2011;70:97-102.
31. Görlinger K, Fries D, Dikmann D, Weber CF, Hanke AA, Schöchl H. Reduction of fresh frozen plasma requirements by perioperative point-of care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother. 2012;39:104-13.
32. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901-11.
33. Winstedt D, Thomas OD, Nilsson F, Olanders K, Schött U. Correction of hypothermic and dilutional coagulopathy with concentrates of fibrinogen and factor XIII: an in vitro study with ROTEM. Scand J Trauma Resusc Emerg Med. 2014;22:73. doi:10.1186/s13049-014-0073-z.
34. Haas T, Görlinger K, Grassetto A, Agostini V, Simioni P, Nardi G, et al. Thromboelastometry for guiding bleeding management of the critically ill patient: a systematic review of the literature. Minerva Anestesiol. 2014;80:1320-35.
35. Schöchl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care. 2011;15:R83.